# The Importance of the Gut Microbiota in Body Weight Control and Insulin Sensitivity

> **NCT02241421** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 57 (actual)

## Conditions studied

- Obesity
- Insulin Resistance

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Vancomycin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02241421
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2020-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02241421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02241421, "The Importance of the Gut Microbiota in Body Weight Control and Insulin Sensitivity". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02241421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*